Cargando…
Preadmission usage of metformin and mortality in COVID-19 patients including the post-discharge period
BACKGROUND: The effect of preadmission metformin usage (PMU) on the mortality of coronavirus disease-2019 (COVID-19) patients with diabetes is conflicting. Most studies have focused on in-hospital mortality; however, mortality after discharge also increases in COVID-19 patients. AIMS: Examining the...
Autores principales: | Saygili, Emre Sedar, Karakiliç, Ersen, Mert, Erdal, Şener, Alper, Mirci, Arzu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553499/ https://www.ncbi.nlm.nih.gov/pubmed/34713419 http://dx.doi.org/10.1007/s11845-021-02823-9 |
Ejemplares similares
-
Subacute thyroiditis after inactive SARS-CoV-2 vaccine
por: Saygılı, Emre Sedar, et al.
Publicado: (2021) -
Some questions about preadmission metformin use and mortality in patients with sepsis and diabetes mellitus
por: Ye, Jiarong, et al.
Publicado: (2019) -
Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study
por: Christiansen, Christian Fynbo, et al.
Publicado: (2013) -
Effect of preadmission beta‐blockade on mortality in multiple trauma
por: Eriksson, M., et al.
Publicado: (2018) -
Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies
por: Liang, Huoyan, et al.
Publicado: (2019)